1.42 USD
↘ 0.01 (0.70%)PRE MARKET (AS OF 04:32 AM EST)
Inovio Pharmaceuticals, Inc. (INO) trades at $1.42 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (209.7%) and a bearish Death Cross on the long-term moving averages. Furthermore, INO is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 13, 2026.